COVID-19 Vaccine-Induced Rhabdomyolysis in a 53-Year-Old Woman

Authors

Akash Hazari, Del Sol Medical CenterFollow
Jack Chien, Del Sol Medical CenterFollow
Daniel Nunez, Del Sol Medical CenterFollow

Keywords

adverse drug reaction; COVID-19 vaccine; rhabdomyolysis; statin

Disciplines

Infectious Disease | Internal Medicine | Nephrology

Abstract

Introduction

COVID-19-induced rhabdomyolysis is a common complication in COVID-19 infection. However, only a handful of cases have been reported showing links between COVID-19 vaccine and rhabdomyolysis.

Case Presentation

We present the case of a 53-year-old woman, who recently received COVID-19 vaccine and presented to the hospital with progressive extremity weakness. Common reasons for rhabdomyolysis were ruled out as possibility and the patient was found to have rhabdomyolysis induced from COVID-19 vaccine.

Conclusion

Even though COVID-19 vaccine-induced rhabdomyolysis is rare, it should be considered in the differential diagnosis with patients presenting with neuromuscular complaints and a recent COVID-19 vaccine.

Recommended Citation

Hazari, Akash; Chien, Jack; and Nunez, Daniel (2025) "COVID-19 Vaccine-Induced Rhabdomyolysis in a 53-Year-Old Woman," HCA Healthcare Journal of Medicine: Vol. 6: Iss. 3, Article 7.
DOI: 10.36518/2689-0216.1463
Available at: https://scholarlycommons.hcahealthcare.com/hcahealthcarejournal/vol6/iss3/7